EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Newsroom

To keep up with the latest news in real-time, subscribe to our email alerts, and follow us on Twitter, Facebook and LinkedIn. If you are a reporter and have questions about the company, please contact us

Latest News

 

Apr 23, 2018

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that its R&D facility's Sagamore Building in Billerica, Massachusetts has been...

Apr 18, 2018

Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its healthcare business in the U.S. and Canada as EMD Serono, today announced 16 abstracts, including two...

Apr 13, 2018

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced data for Cladribine Tablets, an investigational treatment for multiple sclerosis...

Mar 22, 2018

EMD Serono, Inc., the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, today announced that it will collaborate with March of Dimes to launch the March of Dimes...

  All Press Releases

In the News

 

No items to display.

  All In the News